펩티드 합성 시장 예측(-2030년) : 제품별, 기술별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Peptide Synthesis Market is accounted for $5.1 billion in 2023 and is expected to reach $10.2 billion by 2030 growing at a CAGR of 10.2% during the forecast period. The chemical process of forming peptides, which are short chains of amino acids joined by peptide bonds, is known as peptide synthesis. It entails assembling amino acids step-by-step in a predetermined order, and controlling the reaction frequently necessitates the preservation of particular functional groups. There are several ways to synthesize peptides, including solid-phase synthesis, solution-phase synthesis, and recombinant DNA technology.

According to Clinical Trials.gov, 21 peptide drugs were in development for the treatment of COVID-19, including 15 synthetic peptides for acute respiratory distress syndrome (ARDS), a life-threatening condition in which the lungs are unable to provide enough oxygen to the body's vital organs, and other respiratory illnesses caused by SARS-Cov-2 infection.

Market Dynamics:

Driver:

Development of personalized medicines

The peptide synthesis sector has significant growth prospects due to the emergence of customized medicine. The idea of customized medicine is made possible by the ability to customize peptides to fit certain patient profiles. They provide the necessary targeting, customisation, and specificity to enable individualized treatment plans. It is anticipated that the need for peptide synthesis technology, services, and products will increase dramatically as personalized medicine continues to develop and gain popularity.

Restraint:

Problems related to the administrative route

The majority of therapeutic peptides are administered by the parenteral route because of insufficient absorption from the gastrointestinal tract. Peptide medications have a limited oral bioavailability mostly due to pre-systemic enzymatic breakdown. Additionally, the large molecular weight and charged functional groups of these medicines sometimes impede their absorption. These features result in the majority of peptides taken orally having limited bioavailability and brief half-lives. Hence, it can be considered a challenge for the market.

Opportunity:

Advancement in therapeutics for rare diseases

Peptides could be able to cure orphan illnesses and unusual genetic problems. The peptide synthesis sector has significant growth prospects due to the emergence of customized medicine. Peptides provide the necessary targeting, customisation, and specificity to enable individualized treatment plans. It is anticipated that the need for peptide synthesis technology, services, and products will increase dramatically as personalized medicine continues to develop and gain popularity.

Threat:

Purification and quality control

Peptides must be obtained with a high degree of purity in order for research and therapeutic applications to be effective. High-performance liquid chromatography (HPLC) is one of the purification techniques that might take a long time and need to be optimized for every peptide sequence. For synthesized peptides to be accurate, consistent, and safe, quality control procedures are necessary. The market may find it difficult to maintain effective purification procedures and high standards of quality.

COVID-19 Impact:

The pandemic affected the availability of raw materials and equipment required for peptide synthesis by upsetting supply lines around the world. The total distribution and availability of synthesized peptides were impacted by production and shipping delays. The pandemic caused a major shift in the focus of healthcare. Demand for some peptide-based medications or vaccines associated with COVID-19 research may have increased, while interruptions in non-essential healthcare services may have resulted in a decline in demand for other peptide products.

The reagents segment is expected to be the largest during the forecast period

The reagents segment is expected to be the largest during the forecast period. The process of peptide synthesis entails joining amino acids chemically to form peptides. Synthesis times can be shortened by using certain chemicals that promote quicker and more effective peptide bond formation. By reducing side effects and contaminants, using the right reagent can result in a peptide that is more pure. Certain reagents help with the precise coupling of amino acids without producing undesirable reactions since they are very selective.

The pharmaceutical and biotechnology companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical and biotechnology companies segment is expected to have the highest CAGR during the forecast period. Peptide treatments are the subject of more study and development because they are less toxic, efficacious, and cost-effective. Rapid technical improvements in peptide synthesizers and a robust pipeline of peptide therapies are the main factors driving the peptide synthesis industry in pharmaceutical and biotechnology firms.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. Growth in the production of customized therapies, substantial research in the fields of genomics and proteomics, and greater investments in the creation of structure-based medicine designs have all helped the regional market. Additionally, the market will expand due to the increased awareness of the accessible peptide synthesis methods.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The market is expected to develop significantly as a result of the increase in investments made by important players. Furthermore, it is expected that the region's market will grow due to rising awareness of novel peptide treatments, rising healthcare costs, the availability of more cutting-edge healthcare facilities, and significant investments made by the major players in the industry to create new peptide synthesis technologies.

Key players in the market:

Some of the key players in Peptide Synthesis market include Biotage, Genscript Biotech, Thermo Fisher Scientific, Merck KGaA, Creative Diagnostics, CEM Corporation, Bachem Holdings, PuroSynth, Syngene, Lonza, Polypeptide Group, Novo Nordisk A/S, MP Biomedicals and Evonik.

Key Developments:

In January 2023, Merck announced an agreement to acquire the peptide synthesis company Asymchem. This acquisition will give Merck access to Asymchem's expertise in peptide synthesis and its global manufacturing network.

In December 2022, Thermo Fisher announced an agreement to acquire the peptide synthesis company Protagen. This acquisition will give Thermo Fisher access to Protagen's expertise in peptide synthesis and its global manufacturing network.

Products Covered:

• Equipment
• Reagents
• Consumables
• Other Products

Technologies Covered:

• Solution-Phase Peptide Synthesis
• Solid-Phase Peptide Synthesis
• Hybrid & Recombinant Technology

Applications Covered:

• Therapeutics
• Diagnosis
• Research
• Other Applications

End Users Covered:

• Pharmaceutical and Biotechnology Companies
• Contract Manufacturing Organization
• Academic
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Anaysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Peptide Synthesis Market, By Product

• 5.1 Introduction
• 5.2 Equipment
  • 5.2.1 Peptide Synthesizers
  • 5.2.2 Chromatography Equipment
  • 5.2.3 Lyophilizers
• 5.3 Reagents
• 5.4 Consumables
• 5.5 Other Products

6 Global Peptide Synthesis Market, By Technology

• 6.1 Introduction
• 6.2 Solution-Phase Peptide Synthesis
• 6.3 Solid-Phase Peptide Synthesis
• 6.4 Hybrid & Recombinant Technology

7 Global Peptide Synthesis Market, By Application

• 7.1 Introduction
• 7.2 Therapeutics
  • 7.2.1 Metabolic Disorders
  • 7.2.2 Cancer
  • 7.2.3 Respiratory Disorders
  • 7.2.4 Cardiovascular Disorders
  • 7.2.5 Gastrointestinal Disorders
  • 7.2.6 Infectious Diseases
  • 7.2.7 Dermatology Disorders
  • 7.2.8 Pain Management
  • 7.2.9 CNS Disorders
  • 7.2.10 Renal Disorders
  • 7.2.11 Other Therapeutics
• 7.3 Diagnosis
• 7.4 Research
• 7.5 Other Applications

8 Global Peptide Synthesis Market, By End User

• 8.1 Introduction
• 8.2 Pharmaceutical and Biotechnology Companies
• 8.3 Contract Manufacturing Organization
• 8.4 Academic
• 8.5 Other End Users

9 Global Peptide Synthesis Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Biotage
• 11.2 Genscript Biotech
• 11.3 Thermo Fisher Scientific
• 11.4 Merck KGaA
• 11.5 Creative Diagnostics
• 11.6 CEM Corporation
• 11.7 Bachem Holdings
• 11.8 PuroSynth
• 11.9 Syngene
• 11.10 Lonza
• 11.11 Polypeptide Group
• 11.12 Novo Nordisk A/S
• 11.13 MP Biomedicals
• 11.14 Evonik